Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study

被引：5
|
作者：
Winterhalder, R
Deschler-Marini, S
Landmann, C
Kann, R
Passweg, J
Herrmann, R
Pless, M
机构：
[1] Univ Basel Hosp, Dept Oncol, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Radiat Oncol, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 73卷 / 03期
关键词：
low-dose cisplatin and weekly vinorelbine; concomitant chemoradiation; stage IIIBNSCLC;
D O I：
10.1016/j.radonc.2004.06.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In a phase II study. we assessed the toxicity and efficacy of daily low-dose cisplatin (6 mg/m(2)) and weekly vinorelbine (15 mg/m(2)) with concurrent thoracic irradiation (60 Gy) for locally advanced non-metastasized non-small-cell lung cancer. The overall response rate was 65%, complete response 12% and the median overall survival was 64 weeks. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：321 / 324
页数：4
相关论文
共 50 条
  • [41] Treatment of locally advanced non-small cell lung cancer, stage IIIB with irradiation and interferon β:: Preliminary results of a phase II study
    Bund, J
    Eberhardt, K
    Hartmann, W
    Habermalz, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (06) : 300 - 305
  • [42] A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)
    Agelaki, S.
    Kontopodis, E. D.
    Kentepozidis, N.
    Giassas, S.
    Vamvakas, L.
    Androulakis, N.
    Kotsakis, K.
    Sfakiotaki, G.
    Mavroudis, D.
    Georgoulias, V
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S448 - S448
  • [43] Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: A phase I study
    Frasci, G
    Comella, P
    Scoppa, G
    Guida, C
    Gravina, A
    Fiore, F
    Casaretti, R
    Daponte, A
    Parziale, A
    Comella, G
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1409 - 1417
  • [44] PHASE I STUDY OF ORAL S-1 PLUS CISPLATIN WITH CONCURRENT RADIOTHERAPY FOR LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
    Kaira, Kyoichi
    Sunaga, Noriaki
    Yanagitani, Noriko
    Kawata, Tadayoshi
    Utsugi, Mitsuyoshi
    Shimizu, Kimihiro
    Ebara, Takeshi
    Kawamura, Hidemasa
    Nonaka, Tetsuo
    Ishikawa, Hitoshi
    Sakurai, Hideyuki
    Suga, Tatsuo
    Hara, Kenichiro
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Nakano, Takashi
    Mori, Masatomo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (01): : 109 - 114
  • [45] A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated
    Chen, YM
    Perng, RP
    Shih, JF
    Tsai, CM
    Whang-Peng, J
    LUNG CANCER, 2005, 47 (03) : 373 - 380
  • [46] Phase I/II Study of Gemcitabine plus Vinorelbine in Non-Small Cell Lung Cancer
    Emilio Esteban
    Joaquin Fra
    Norberto Corral
    Miguel Valle
    Juan Carrasco
    Marian Sala
    Javier Puerta
    Enrique Estrada
    Isabel Palacio
    Jose Maria Vieitez
    Jose Maria Buesa
    Angel Jimenez Lacave
    Investigational New Drugs, 2002, 20 : 73 - 82
  • [47] Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer
    Esteban, E
    Fra, J
    Corral, N
    Valle, M
    Carrasco, J
    Sala, M
    Puerta, J
    Estrada, E
    Palacio, I
    Vieitez, JM
    Buesa, JM
    Lacave, AJ
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (01) : 73 - 82
  • [48] Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
    Lorusso, V
    Carpagnano, F
    Frasci, G
    Panza, N
    Di Rienzo, G
    Cisternino, ML
    Napoli, G
    Orlando, S
    Cinieri, S
    Brunetti, C
    Palazzo, S
    De Lena, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 405 - 411
  • [49] Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer
    Biedermann, B
    Landmann, C
    Kann, R
    Passweg, J
    Solèr, M
    Lohri, A
    Rochlitz, C
    Herrmann, R
    Pless, M
    RADIOTHERAPY AND ONCOLOGY, 2000, 56 (02) : 169 - 173
  • [50] Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB+ IV) non-small-cell lung cancer (NSCLC).: A phase II study of the Galician Lung Cancer Group
    Vázquez, S
    Villanueva, M
    Amenedo, M
    Fírvida, J
    Lázaro, M
    Del Rio, L
    Huidobro, G
    Mei, J
    Ramos, M
    Grande, C
    LUNG CANCER, 2005, 49 : S273 - S273
12345